DataMeds AI, Inc.: reports stockholders’ equity greater than $2,500,000

What happened The filing says that as of Oct 13, 2026, DataMeds AI, Inc. confirms its stockholders’ equity is greater than $2,500,000. The filing says the Company entered into a settlement agreement and release on Sep 11, 2026 with Brian Norton, Tony Madsen, Mark DiSiena, T. Scott Madsen, Stephen J. Madsen, RxERP, Inc. d/b/a RxERP, Nomad Capital LLC and Strategix Global LLC. The filing says the Company paid $450,000 under that agreement, and the Company entered into a license agreement with REBOOT Health AI, Inc. on Oct 13, 2026 and issued 666,667 shares of common stock to REBOOT.

Key details

• The Company paid $450,000 under the settlement: $350,000 attributed to repurchase and extinguishment of 364,099 shares of common stock and $100,000 for compromise and settlement of the MIPA and other released claims.
• The filing says the settlement resulted in extinguishing approximately $19,000,000 in liability on the Company’s consolidated balance sheet.
• The settlement resolved state-court and Delaware Court of Chancery actions involving the Membership Interest Purchase Agreement dated May 11, 2023, as amended.
• On Oct 13, 2026, the Company licensed a care management platform from REBOOT and issued 666,667 shares of common stock to REBOOT.

Why it may matter The filing reports Item 8.01 (Other events), which covers other material events not reported under other items; here the Company reports the settlement agreement, the related payments and share repurchase/extinguishment, and the license and share issuance to REBOOT. A filing does not show why the insider traded or why the company acted.